Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAREGIVER: Intrathecal Drug Delivery vs Comprehensive Medical Management for Severe Cancer Pain
NCT07691840Recruiting
- Sponsor
- UZ Brussel
- Start
- Jul 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in cancer pain (2 arms), sponsored by UZ Brussel. Primary endpoint: Health-related quality of life at 12 months. Started Jul 2026; status: recruiting.
02
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07691840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691840.